CDXS · Codexis Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 1.29 USD |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 28 / 7 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 22 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +150.0% |
| Sales growth Q/Q | +352.4% |
| Distance from 52-week high | +54.7% |
| Market cap (USD) | $229.0M |